Ladarixin sodium
Cat. No.：YN322833
CAS No. ：865625-56-5
| 产品名称: | Ladarixin sodium |
| CAS No.: | 865625-56-5 |
| Chemical Name: | DF 2156A; [(R)-(-)-2-(4-Trifluoroomethanesulfonyloxy)phenyl]-N-methanesulfonylpropionamide Sodium; (R)-(-)-2-(4-Trifluoroomethanesulfonyloxy)phenyl]-N-methanesulfonylpropionamide Sodium |
| Synonyms: | DF 2156A |
| 分子量: | 397.315 |
| 分子式: | C11H11F3NNaO6S2 |
| SMILES: | 暂无 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Ladarixin sodium (DF 2156A) 是一种具有口服活性的，非竞争性的CXCR1和CXCR2的变构抑制剂。Ladarixin sodium 可用于 COPD 和哮喘的研究。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Kemp, D. M., et al.: Oncotarget. 8, 14428 (2017)
Citro, A., et al.: Diabetes 64, 1329 (2015)
